Health committee  I can answer from the point of view of a community pharmacist. We systematically ask patients if they are taking any other medication before we dispense any drug. Once again, it comes down to educating patients. Moreover, the federal government ran a campaign two years ago seeki

Health committee  Could I please add something on frequency? The question of frequency is an interesting one. Increasingly, we have access to data comparing the frequency of adverse reactions experienced by patients taking a given drug compared to those experienced by patients taking a placebo, a

Health committee  Obviously, there would be merit in reporting all adverse reactions, but you have to bear in mind that the feedback would come from patients and would be in their words. How would we, as professionals, manage this additional information that is already known to us? Firstly, the

Health committee  From a practitioner's perspective, it is already very difficult to explain adverse drug reactions to patients. It would be all the more difficult if we had to then say that a given ADR is experienced by one patient in a million. How do you make this sort of information accessible

Health committee  First of all, thank you for having invited us and for allowing me, as a community pharmacist who has worked in my field for 30 years, to come and share my thoughts with you. The Canadian Pharmacy Association strongly supports measures to increase patient safety, including incre